medigraphic.com
ISSN 1684-1824 (Electronic)

2012, Number 1

<< Back Next >>

Rev Méd Electrón 2012; 34 (1)

Behavior of the serologic markers in blood donors in the territory of Colon, 1998-2007

Pereira MMM, Noda AA, Hernández OA, Muy SL, Martínez DJ, Rego DR

Language: Spanish
References: 14
Page:
PDF size: 82.39 Kb.


ABSTRACT

We carried out a prospective descriptive longitudinal study on the behavior of the serologic markers in the Ultra-Micro-Analytic System laboratory, of the blood bank of the territorial university hospital Dr. Mario Muñoz Monroy, of the municipality of Colon, province of Matanzas. We determined the incidence and prevalence of the surface Hepatitis B virus antigen (HBV, HBsAg) and of the antibodies against the Hepatitis C (HCV, anti HCV) and the human immunodeficiency virus 1 and 2 (HIV 1 and 2, anti-HIV 1+2) in blood donors of the territory, and the estimate of non-detected potential infection transmissible by blood or residual risk (RR) in the donated blood, in the period from January 1st 1998 to December 31st 2007. The research was made with all the universe of utile donors and their respective blood donations, and was formed by 49 749 donors and 84 932 blood bags. The prevalence rates (x 100 000 donors), incidence (x 100 000 donors), and estimated residual risk (x 1 000 000 units of donated blood) in the quoted time period were: for the HBV 0,81; 0,17 and 0,20; for the HCV 0,55; 0,12 and 0,23, and for the HIV 1 and 2 0,005; 0,01x10-2 and 0,02x10-3 respectively, low rates according to the international classification, but not for Cuba with respect of the HBsAg.


REFERENCES

  1. Ballester JM. ABC de la medicina transfusional: Guías Clínicas; 2006.

  2. Ballester JM, Alfonso ME, Ballester L. Procederes para bancos de sangre y servicios de transfusiones. La Habana: MINSAP; 2004.

  3. Rivero Jiménez RA. Transmisión de infecciones virales por la transfusión de sangre. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2006[citado 12 May 2011];22(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=0864-028920060002&lng=es&nrm=iso

  4. Cué BM. La sangre, el fluido de la vida; 2008.

  5. Insert UMELISA HBsAg, UMELISA HCV, UMELISA HIV (1+2) RECOMBINANT. La Habana: Centro de Inmunoensayos; 2005.

  6. Navarro D, Panchuck P, Villalba Salinas V, Salazar M, Merino D, Balbachán S. Hepatitis B, C y en coinfección con VIH en un Banco de Sangre en Corrientes, Argentina. Rev Cubana de Medicina Tropical [Internet]. 2008 [citado 12 May 2011];60(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=0375-076020080002&lng=es&nrm=iso

  7. Pérez D. Salim M. Prevalencia de marcadores infecciosos en el Banco de sangre del hospital San Jerónimo de Montería: 2001- 2007. Infectio [Internet]. 2003 [citado 12 May 2011];7(1):15-20. Disponible en: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS&lang=p&nextAction=lnk&exprSearch=422688&indexSearch=ID

  8. Suárez G, Eranilde L, De Freitas F. Prevalencia de enfermedades infecciosas de transmisión sanguínea en donantes que asisten al Banco de Sangre del Hospital Universitario “Antonio Patricio de Alcalá”, Cumaná, Estado Sucre; 2008.

  9. Mahtab MA, Rahman S, Karim MF. Epidemiology of hepatitis B virus in Bangladeshi blood donors. Hepatobiliary Pancreat. Dis Int. 2008;7(6):595-600.

  10. El Beltagy KE, Al Balawi IA, Almuneef M, Memish Ziad A. P revalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis [Internet]. 2008 [citado 12 may 2011];12(5):495-9. Disponible en: http://cat.inist.fr/?aModele=afficheN&cpsidt=20674876

  11. Duberg A, Janzon R, Bäck E, Ekdahl K, Blaxhult A. The epidemiology of HCV infection in Sweden. Euro Surveill [Internet]. 2008 [citado 12 may 2011]; 13 (21). Disponible en: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=ADOLEC&lang=p&nextAction=lnk&exprSearch=18761966&indexSearch=ID

  12. Pillonel J, Laperche S, Saura C. Trends in residual risk of transfusion transmitted viral infections in France between 2000 and 2006. Transfusion 2007;47(4):1080-95.

  13. Chiavetta JA, Escobar M, Newman A. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses. CMAJ. 2004;14:169(8).

  14. Barreto CC, Rodrigues FP, Teles SA. Prevalence, incidence, and residual isk of human immunodeficiency virus among community and replacement first - time blood donors in Sao Paulo, Brazil. Transfusion (Paris). 2005;45(11):1709 -14.




2020     |     www.medigraphic.com